Skip to main content
logo
Biocon Limited (BOM:532523)
India flag India · Delayed Price · Currency is INR
428.25
-3.15 (-0.73%)
At close: May 29, 2026

Biocon Revenue

In the fiscal year ending March 31, 2026, Biocon had annual revenue of 169.27B INR with 10.91% growth. Biocon had revenue of 45.17B in the quarter ending March 31, 2026, with 2.25% growth.

Revenue
169.27B
Revenue Growth
+10.91%
P/S Ratio
4.10
Revenue / Employee
10.31M
Employees
16,420
Market Cap
693.71B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026169.27B16.65B10.91%
Mar 31, 2025152.62B5.06B3.43%
Mar 31, 2024147.56B35.82B32.05%
Mar 31, 2023111.74B29.90B36.54%
Mar 31, 202281.84B10.41B14.57%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Aarti Drugs25.65B
Hester Biosciences3.33B
Titan Biotech2.12B
Zenotech Laboratories395.62M
Bharat Immunologicals & Biologicals Corporation76.50M
CCME Global36.67M
Hindustan Bio Sciences7.37M
Transgene Biotek3.61M
Revenue Rankings

Biocon News

More News